| Date Filed | Type | Description |
| 02/11/2011 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 11/05/2010 |
3
| GIBSON TERRY (CEO and CFO) has filed a Form 3 on ORE PHARMACEUTICAL HOLDINGS INC. |
| 11/01/2010 |
3
| HOWARD JACK L (Director) has filed a Form 3 on ORE PHARMACEUTICAL HOLDINGS INC. |
| 11/01/2010 |
3
| Kong Kenneth (Director) has filed a Form 3 on ORE PHARMACEUTICAL HOLDINGS INC. |
| 11/01/2010 |
SC 13D
| Steel Partners, Ltd. reports a 41.5% stake in Ore Pharmaceutical Holdings Inc. |
| 10/29/2010 |
4
| Steel Partners, Ltd. (10% Owner) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 125,000 shares
@ $0.255, valued at
$31.9k
Bought 68,000 shares
@ $0.255, valued at
$17.3k
|
|
| 10/29/2010 |
3
| Steel Partners, Ltd. (10% Owner) has filed a Form 3 on ORE PHARMACEUTICAL HOLDINGS INC. |
| 09/24/2010 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)] |
| 08/11/2010 |
10-Q
| Quarterly Report for the period ended June 30, 2010 |
| 07/22/2010 |
8-K
| Quarterly results |
| 05/11/2010 |
10-Q
| Quarterly Report for the period ended March 31, 2010 |
| 04/29/2010 |
10-K/A
| Annual Report for the period ended December 31, 2009 [amend] |
| 04/19/2010 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 04/05/2010 |
25-NSE
| Form 25-NSE - |
| 03/31/2010 |
10-K
| Annual Report for the period ended December 31, 2009 |
| 03/22/2010 |
8-K
| Form 8-K - Current report |
| 02/12/2010 |
8-K
| Form 8-K - Current report |
| 02/12/2010 |
SC 13G/A
| GENE LOGIC INC reports a 6.6% stake in ORE PHARMACEUTICAL HOLDINGS INC. |
| 02/03/2010 |
8-K
| Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arran... |
| 01/20/2010 |
4
| Donahue Stephen R (Senior Vice President) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 2,500 options to buy
@ $0.57, valued at
$1.4k
|
|
| 01/20/2010 |
4
| Palleiko Benjamin L (SVP & CFO) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 6,250 options to buy
@ $0.57, valued at
$3.6k
|
|
| 12/02/2009 |
4
| Gabrielson Mark J (CEO) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.62, valued at
$1.2k
|
|
| 12/01/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.55, valued at
$1.1k
|
|
| 11/25/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.575, valued at
$1.2k
Bought 2,000 shares
@ $0.575, valued at
$1.2k
|
|
| 11/23/2009 |
4
| Gabrielson Mark J (CEO) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.62, valued at
$1.2k
Bought 1,980 shares
@ $0.64, valued at
$1.3k
Bought 20 shares
@ $0.62, valued at
$12.4 |
|
| 11/23/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 2,000 shares
@ $0.64, valued at
$1.3k
|
|
| 11/20/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Bought 300 shares
@ $0.6327, valued at
$189.8
Bought 1,700 shares
@ $0.6336, valued at
$1.1k
|
|
| 11/16/2009 |
S-8
| Form S-8 - Securities to be offered to employees in employee benefit plans |
| 11/16/2009 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments |
| 11/13/2009 |
10-Q
| Quarterly Report for the period ended September 30, 2009 |
| 11/13/2009 |
8-K
| Form 8-K - Current report |
| 10/22/2009 |
4
| THOMPSON J STARK PHD (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
| 10/22/2009 |
4
| FORDYCE JAMES W (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
| 10/22/2009 |
4
| URDAL DAVID (Director) has filed a Form 4 on ORE PHARMACEUTICAL HOLDINGS INC.|
Txns:
| Granted 40,000 options to buy
@ $0.7262, valued at
$29k
|
|
|